Showing 1 to 1 of 1 results
smh.com.au
🌐 85% Global Worthiness
Australia's Slow Drug Subsidy Process Sparks US Trade Dispute
Australia's Pharmaceutical Benefits Scheme (PBS) faces delays averaging 466 days for new drug subsidies, compared to 90 days in other countries, impacting patient access and drawing US trade concerns, prompting a government review with 50 recommendations for improvement.
Australia's Slow Drug Subsidy Process Sparks US Trade Dispute
Australia's Pharmaceutical Benefits Scheme (PBS) faces delays averaging 466 days for new drug subsidies, compared to 90 days in other countries, impacting patient access and drawing US trade concerns, prompting a government review with 50 recommendations for improvement.
Progress
48% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results